With regulators embracing next-generation sequencing, how will the ICH Q5A(R2) guidelines reshape viral safety strategies for gene and cell therapies?
Amina Cherif Louazani, PharmD, PhD
Advertisement
Articles by Amina Cherif Louazani, PharmD, PhD
Advertisement
Latest Updated Articles
Viral Clearance & Viral Safety: Industry Trends & Key EventsPublished: May 9th 2025 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Everything to Know About Cell and Gene Therapy in 2025
3
Why Product-Specific Strategies Matter in Advanced Therapy Manufacturing (Part 3)
4
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
5
